ARCHIVED


Medical Policy

Policy Num:       06.001.048
Policy Name:     NON INVASIVE EVALUATION OF EXTRACRANIAL ARTERIES
Policy ID:          [06.001.048]   [Ar / L / M+ / P ]   [0.00.00]


Last Review:       January 13, 2025

Next Review:      ARCHIVED
 

Related Policies:

None

NON INVASIVE EVALUATION OF EXTRACRANIAL ARTERIES

Popultation Reference No.

Populations

Interventions

Comparators

Outcomes

1

Individuals:
  • presenting with an asymptomatic carotid bruit identified on physical examination.
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

2

Individuals:
  • with an symptomatic  carotid bruit(s)
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

3

Individuals:
  • with known carotid stenosis
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

4

Individuals:
  • who has had a recent stroke (recent is defined as less than six months) to determine the cause of the stroke.
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

5

Individuals:
  • with focal cerebral or ocular transient ischemic symptoms. 
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

6

Individuals:
  • with syncope that is strongly suggestive of vertebrobasilar or bilateral carotid artery disease in etiology, as suggested by medical history.
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

7

Individuals:
  • with retinal arterial emboli (Hollenhorst plaques)
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

8

Individuals:
  • with transient monocular blindness (amaurosis fugax)
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

9

Individuals:
  • with signs/symptoms of subclavian steal syndrome. 
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

10

Individuals:
  • with proven carotid disease on medical management in whom cerebrovascular symptoms become recurrent.
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

11

Individuals:
  •  presenting with an injury to the carotid artery or blunt neck trauma.
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

12

Individuals:
  • with vasculitis involving the extracranial carotid arteries.
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

13

Individuals:
  • with a suspected aneurysm of the carotid artery. This is suspected in patients with swelling of the neck particularly if occurring post carotid endarterectomy.
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

14

Individuals:
  • with suspected dissection.
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

15

Individuals:

  • with pulsatile neck masses.
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

16

Individuals:

  •  who are post carotid endarterectomy.
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

17

Individuals:

  • whose previous duplex scan revealed a greater than 70% diameter reduction to preoperatively validate the degree of carotid stenosis
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

18

Individuals:

  • scheduled for major cardiovascular surgical procedures when there is evidence of systemic atherosclerosis.
Interventions of interest are:
  • Carotid doppler arteries ultrasound
Comparators of interest are:
  • Clinical diagnosis

Relevant outcomes include:

  • Funtional outcomes
  • Quality of life

Summary

Non-invasive studies of the extracranial arteries consist of the direct and indirect use of ultrasound methods. The direct tests examine the anatomy and the physiology of the carotid artery while the indirect tests evaluate the hemodynamic changes of its distal branches (the orbital and brain circulation).

Ultrasonography by Doppler evaluates the hemodynamic parameters particularly the speed of blood flow and the characteristics of the flow. This modality evaluates the supraorbital arteries, common carotid, external carotid, internal carotid and vertebral arteries of the neck.

There are two types of peripheral arterial studies:

 ·         Physiological studies - these studies are of functional measures that include analysis of Doppler wave with response to the compression, measures of transcutaneous                   oxygen pressure or plethysmography.

 ·         A duplex scanning is an ultrasonic study where images and structures are shown in two dimensions and in real time. It also includes a spectral analysis with speed of                   blood flow.

Objective

The evaluation of the extracranial arteries is of utility to evaluate a patient that presents an asymptomatic carotid bruit but that is identified in a physical examination. Also it is of utility in the evaluation of a patient that has suffered a brain hemorrhage recently.

Policy Statements

Non-invasive studies are recognized for payment if the results impact the clinical course of the patient, for example, they are considered unnecessary when the patient requires

other diagnostic tests or treatments regardless of the outcome of the non-invasive studies.

Performing non-invasive extracranial studies (CPT 93880 or 93881) and evaluation Non-invasive limb veins (CPT 93965, 93970 or 93971) in it encounter is not appropriate as a

general practice or accepted protocol and consequently they should not be billed.


Non-invasive physiological studies of extracranial arteries are considered for payment in the evaluation of the following conditions:

• Carotid puffs

• Monitoring of the patient with known carotid stenosis

• Stroke evaluation

• Evaluation of a transient cerebral ischemic attack

 • Evaluation of a patient with syncope and symptoms suggestive of arterial disease
  vertebrobasilar

• In the preoperative evaluation of a carotid endarterectomy

• In the evaluation of pulsatile masses in the neck

• In the evaluation of amaurosis fugax

• In the evaluation of a patient with vasculitis involving the carotid arteries
  extracranial

Policy Guidelines

Non-invasive vascular studies are medically necessary only if the outcome will potentially impact the clinical management of the patient. Services are deemed medically necessary when all of the following conditions are met:

1) Significant signs/symptoms of ischemia are present;

2) The information is necessary for appropriate medical and/or surgical management; and

3) The test is not redundant of other diagnostic procedures that must be performed.

Limitations:

  • Dizziness is not a typical indication unless associated with other localizing signs or symptoms. However, episodic dizziness with symptom characteristics typical of transient ischemic attacks may indicate medical necessity, especially when other more common sources (eg, postural hypotension, arrhythmia or transiently decreased cardiac output as demonstrated by cardiac events monitoring) have been previously excluded.
  • When reporting syncope as an indication for this service, it is necessary to document that other, more common causes have been ruled out.
  • When an uninterpretable study results in performing another type of study, only the successful study should be billed.
  • Non-invasive studies are reasonable and necessary only if the outcome will potentially impact the clinical course of the patient.

Benefit Application

BlueCard/National Account Issues

Not applicable.

Background

Non-invasive extracranial arterial studies will be considered medically reasonable and necessary under the following
circumstances:
• To initially evaluate a patient presenting with an asymptomatic carotid bruit identified on physical examination. However,
repeatedly using this test for a patient with an asymptomatic carotid bruit with no evidence of carotid stenosis is routine
monitoring. As such, it is considered screening and is noncovered.
• To evaluate a symptomatic patient with a carotid bruit(s).
• To monitor a patient with known carotid stenosis. Patients demonstrating a diameter reduction of 30-50% are normally
followed on an annual basis, whereas patients with a diameter reduction of greater than 50% are normally followed every
six months. It is not necessary to monitor patients with a diameter reduction of less than 30%.
• To initially evaluate a patient who has had a recent stroke (recent is defined as less than six months)to determine the cause of the stroke.
• To evaluate a patient with focal cerebral or ocular transient ischemic symptoms (including, but not limited to, localizing symptoms, weakness of one side of the face, slurred speech, weakness of limb, ocular microembolism, arterial occlusions on retinal examination (branch or central), ischemic optic neuropathy, suspected dural or carotid cavernous fistulae). Ocular transient ischemic attacks are defined as retinal or visual field deficits and not temporarily blurred vision.
• To evaluate a patient with syncope that is strongly suggestive of vertebrobasilar or bilateral    carotid artery disease in etiology, as suggested by medical history.
• To evaluate a patient with retinal arterial emboli (Hollenhorst plaques)
• To evaluate a patient with transient monocular blindness (amaurosis fugax).
• To evaluate a patient with signs/symptoms of subclavian steal syndrome. The symptoms usually associated with subclavian steal syndrome are a bruit in the supraclavicular fossa, unequal radial pulses, arm claudication following minimal exercise, and a difference of 20mmHg or more between the systolic blood pressures in the arms.
• To evaluate a patient with proven carotid disease on medical management in whom cerebrovascular symptoms become recurrent.
• To evaluate a patient presenting with an injury to the carotid artery or blunt neck trauma.
• To evaluate a patient with vasculitis involving the extracranial carotid arteries.
• To evaluate a patient with a suspected aneurysm of the carotid artery. This is suspected in patients with swelling of the neck particularly if occurring post carotid endarterectomy.
• To evaluate a patient with suspected dissection
To evaluate pulsatile neck masses.
• To monitor patients who are post carotid endarterectomy. These patients are normally followed with duplex ultrasonography on the affected side at 6 weeks, 6 months, 1 year, and annually thereafter.
• To preoperatively validate the degree of carotid stenosis of a patient whose previous duplex scan revealed a greater than 70% diameter reduction. The duplex is only covered when the surgeon questions the validity of the previous study and the repeat test is being performed in lieu of a carotid arteriogram.
Preoperative evaluation of patients scheduled for major cardiovascular surgical procedures when there is evidence of systemic atherosclerosis.
Non-invasive vascular studies are medically necessary only if the outcome will potentially impact the clinical management
of the patient. Services are deemed medically necessary when all of the following conditions are met:
1) Significant signs/symptoms of ischemia are present;
2) The information is necessary for appropriate medical and/or surgical management; and
3) The test is not redundant of other diagnostic procedures that must be performed.

Limitations:
• Dizziness is not a typical indication unless associated with other localizing signs or symptoms. However, episodic dizziness with symptom characteristics typical of transient ischemic attacks may indicate medical necessity, especially when other more common sources (eg, postural hypotension, arrhythmia or transiently decreased cardiac output as demonstrated by cardiac events monitoring) have been previously excluded.
• When reporting syncope as an indication for this service, it is necessary to document that other, more common causes have been ruled out.
• When an uninterpretable study results in performing another type of study, only the successful study should be billed.
• Non-invasive studies are reasonable and necessary only if the outcome will potentially impact the clinical course of the patient. For example, the studies are unnecessary when the patient is (or is not) proceeding on to other diagnostic and/or therapeutic procedures regardless of the outcome of the non-invasive studies. If it is obvious from the findings of the history and physical examination that the patient is going to proceed to angiography, then non-invasive vascular studies are not medically necessary.
• Performance of both non-invasive extracranial arterial studies (CPT codes 93880 or 93882) and non- invasive evaluation of extremity veins (CPT codes 93970 or 93971) during the same encounter is not appropriate as a general practice or standing protocol, and therefore, would not generally be expected (American College of Radiology, 2010).
Consequently, documentation must clearly support the medical necessity if both procedures are performed during the same encounter, and be available upon request.
Methods Not Acceptable For Reimbursement:

• Pulse delay oculoplethysmography
• Carotid phonoangiography and other forms of bruit analysis are covered services, but are included in the reimbursement for the office visit
• Periorbital photoplethysmography
• Thermography
• Light reflection rheography
• Photoelectric plethysmograph,
• Mechanical oscillometry
• Inductance plethysmography
• Capitance plethysmography

The use of a simple hand-held or other Doppler device that does not produce hard copy output, or that produces a record that does not permit analysis of bidirectional vascular flow, is considered part of the physical examination of the vascular system and is not separately reported (CPT 2010). The appropriate assignment of a specific ultrasound CPT code is not solely determined by the weight, size, or portability of the equipment, but rather by the extent, quality, and documentation of the procedure. If an examination is performed with hand- carried equipment, the quality of the exam, printout, and report must be in keeping with accepted national standards. Since, the standard for the above indications is a color-duplex scan, portable equipment must be able to produce combined anatomic and spectral flow measurements
 

Regulatory Status

Not applicable.

Rationale

Population Reference No. 1 Policy Statement

Individuals presenting with an asymptomatic carotid bruit identified on physical examination. Interventions of interest are carotid doppler arteries ultrasound. Comparators of interest are clinical diagnosis. Relevant outcomes include funtional outcomes and quality of life

Population Reference No. 1 Policy Statement [ x ] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 2 Policy Statement

Individuals with an symptomatic  carotid bruit(s). Interventions of interest are carotid doppler arteries ultrasound. Comparators of interest are clinical diagnosis. Relevant outcomes include Funtional outcomes and Quality of life

Population Reference No. 2 Policy Statement [ x ] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 3 Policy Statement

Individuals with known carotid stenosis. Interventions of interest are carotid doppler arteries ultrasound. Comparators of interest are clinical diagnosis. Relevant outcomes include funtional outcomes and quality of life.

Population Reference No. 3 Policy Statement [ x ] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 4 Policy Statement

Individuals who has had a recent stroke (recent is defined as less than six months) to determine the cause of the stroke. Interventions of interest are carotid doppler arteries ultrasound. Comparators of interest are clinical diagnosis. Relevant outcomes include funtional outcomes  and quality of life.

Population Reference No. 4 Policy Statement [ x ] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 5 Policy Statement

Individuals with focal cerebral or ocular transient ischemic symptoms. Interventions of interest are carotid doppler arteries ultrasound. Comparators of interest are clinical diagnosis. Relevant outcomes include funtional outcomes and quality of life.

Population Reference No. 5 Policy Statement [ x ] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 6 Policy Statement

Individuals:with syncope that is strongly suggestive of vertebrobasilar or bilateral carotid artery disease in etiology, as suggested by medical history.    Interventions of interest are:Carotid doppler arteries ultrasound    Comparators of interest are:Clinical diagnosis    Relevant outcomes include:Funtional outcomesQuality of life

Population Reference No. 6 Policy Statement [ x ] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 7 Policy Statement

Individuals with retinal arterial emboli (Hollenhorst plaques). Interventions of interest are:Carotid doppler arteries ultrasound. Comparators of interest are:Clinical diagnosis. Relevant outcomes include:Funtional outcomes quality of life.

Population Reference No. 7 Policy Statement [ x ] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 8 Policy Statement

Individuals with transient monocular blindness (amaurosis fugax).  Interventions of interest are:Carotid doppler arteries ultrasound. Comparators of interest are:Clinical diagnosis.  Relevant outcomes include:Funtional outcomes and Quality of life.

Population Reference No. 8 Policy Statement [ x ] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 9 Policy Statement

Individuals:with signs/symptoms of subclavian steal syndrome.  Interventions of interest are:Carotid doppler arteries ultrasound. Comparators of interest are:Clinical diagnosis.   Relevant outcomes include:Funtional outcomes and Quality of life

Population Reference No. 9 Policy Statement [ x ] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 10 Policy Statement

Individuals:with proven carotid disease on medical management in whom cerebrovascular symptoms become recurrent.    Interventions of interest are:Carotid doppler arteries ultrasound.   Comparators of interest are:Clinical diagnosis.  Relevant outcomes include:Funtional outcomes and Quality of life

Population Reference No. 10 Policy Statement [X ] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 11 Policy Statement

Individuals presenting with an injury to the carotid artery or blunt neck trauma. Interventions of interest are:Carotid doppler arteries ultrasound. Comparators of interest are:Clinical diagnosis. Relevant outcomes include:Funtional outcomes and Quality of life.

Population Reference No. 11 Policy Statement [ X] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 12 Policy Statement

Individuals:with vasculitis involving the extracranial carotid arteries.  Interventions of interest are:Carotid doppler arteries ultrasound. Comparators of interest are:Clinical diagnosis. Relevant outcomes include:Funtional outcomes and Quality of life.

Population Reference No. 12Policy Statement [X] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 13 Policy Statement

Individuals with a suspected aneurysm of the carotid artery. This is suspected in patients with swelling of the neck particularly if occurring post carotid endarterectomy.    Interventions of interest are:Carotid doppler arteries ultrasound.  Comparators of interest are:Clinical diagnosis    Relevant outcomes include:Funtional outcomesand quality life

Population Reference No. 13Policy Statement [X MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 14 Policy Statement

Individuals:with suspected dissection.   Interventions of interest are:Carotid doppler arteries ultrasound.  Comparators of interest are:Clinical diagnosis. Relevant outcomes include:Funtional outcomes and quality of life.

Population Reference No. 14Policy Statement [X ] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 15 Policy Statement

Individuals:with pulsatile neck masses.  Interventions of interest are:Carotid doppler arteries ultrasound.  Comparators of interest are:Clinical diagnosis    Relevant outcomes include:Funtional outcomes and quality of life.

Population Reference No. 15Policy Statement [ x ] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 16 Policy Statement

Individuals: who are post carotid endarterectomy.    Interventions of interest are:Carotid doppler arteries ultrasound    Comparators of interest are:Clinical diagnosis    Relevant outcomes include:Funtional outcomesQuality of life.

Population Reference No. 16 Policy Statement [x ] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 17 Policy Statement

Individuals:whose previous duplex scan revealed a greater than 70% diameter reduction to preoperatively validate the degree of carotid stenosis    Interventions of interest are:Carotid doppler arteries ultrasound.   Comparators of interest are:Clinical diagnosis.   Relevant outcomes include:Funtional outcomesQuality of life.

Population Reference No. 17 Policy Statement [ x ] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Population Reference No. 18 Policy Statement

Individuals:scheduled for major cardiovascular surgical procedures when there is evidence of systemic atherosclerosis.  Interventions of interest are:Carotid doppler arteries ultrasound.   Comparators of interest are:Clinical diagnosis.   Relevant outcomes include:Funtional outcomesQuality of life.

Population Reference No. 18 Policy Statement [ x ] MedicallyNecessary [ ] Investigational [ ] Not Medically Necessary

Supplemental InformatioN

Practice Guidelines and Position Statements

N/A

Medicare National Coverage

Language quoted from CMS National Coverage Determinations (NCDs) and coverage provisions in interpretive manuals are italicized throughout the Local Coverage Determination (LCD). NCDs and coverage provisions in interpretive manuals are not subject to the LCD Review Process (42 CFR 405.860[b] and 42 CFR 426 [Subpart D]). In addition, an administrative law judge may not review an NCD. See §1869(f)(1)(A)(i) of the Social Security Act.

References

1. Abuhamad, A., Benacerraf, B., Woletz, P., Burke, B. (2004). The accreditation of ultrasound practices – Impact on compliance with minimum performance  

    guidelines. J Ultrasound Med, 23, 1023-1029. American College of Radiology Practice Guidelines (2007). ACR practice guideline for the performance of an   

    ultrasound examination of the extracranial cerebrovascular system. Retrieved from http://www.acr.org

2. Beers, M., Berkow, R. (Eds.). (2005). Ischemic Syndromes. The Merck Manual of Diagnosis and Therapy (17 ed.), 165-184. Retrieved         

    from http://www.merck.com/mrkshared/mmanual/section14/chapter174/174b.jsp on December 27, 2005.

3. Brophy, D. (2005). Subclavian Steal Syndrome. Retrieved from http://www.emedicine.com/radio/topic663.htm on September 9, 2005.

4. Caplan, L. (2004). Clinical diagnosis of patiens with cerebrovascular disease. Prim Care, 31(1), 95-109. Retrieved from

    http://home.mdconsult.com/das/article/body/53475846- 2/jorg on December 30, 2005.

5. Cina, C., Clase, C., Radan, A. (2004). Aysmptomatic Carotid Bruit. ACS Surgery. Retrieved from http://www.medscape.com/viewarticle/506635 on

    September 9, 2005.

6. Hill, M., Foss., Tu., Feasby, T. (2004). Factors influencing the decision to perform carotid endarterectomy. Neurology 62(5). American Academy of Neurology.

7. Retrieved from http://home.mdconsult/das/article/body/50235942-2/jorg on September 9, 2005.

8. Mettler, F. (2005). Essentials of Radiology, second edition. Page 149. Elsevier, Inc. Retrieved from http://home.mdconsult.com/das/book/body/0/1276/1.html

    on September 9, 2005.

9. Purvin, V. (2004). Cerebrovascular disease and the visual system. Ophthalmol Clin North Am, 17(3), 329-355. Retrieved from

    http://home.mdconsult.com.das/article/body/53475846-2/jorg on December 27, 2005.

10.Rowe, V. Tucker, S. (2004). Advances in vascular imaging. Surg Clin North Am, 84(5), 1189-1202. Retrieved from         

     http://home.mdconsult.com/das/article/body/53475846-2/jorg on December 27, 2005. Shah, K., Edlow, J. (2004). Transient ischemic attack: Review for the

     emergency physician. Annals of Emergency Medicine 43(5). Retrieved from http://home.mdconsult.com/das/article/body/50211775-2/jorg on September 9,

     2005. Society for Vascular Ultrasound – Professional performance guidelines. (2003). Transcranial doppler (non-imaging). Retrieved from

     http://www.svunet.org/about/positions on December 28, 2005. Tusa, R. (2003). Dizziness. Med Clin North Am, 87(3), 609-641. Retrieved from

     http://home.mdconsult.com/das/article/body/53542946-2-jorg on 12/30/2005.

11.First Coast Service Option, Inc. L29321.

12.O'Donnell TF Jr, Erdoes L, Mackey WC, et al. Correlation of B-mode ultrasound imaging and arteriography with pathologic findings at carotid  endarterectomy. Arch Surg 1985;120:443.

13.Criswell BK, Langsfeld M, Tullis MJ, Marek J. Evaluating institutional variability of duplex scanning in the detection of carotid artery stenosis. Am J Surg

     1998; 176:591

Codes

CODES

Number

Description

 

 CPT

 

93880

Duplex scan of extracranial arteries; complete bilateral study

93882

Duplex scan of extracranial arteries; unilateral or limited study

ICD 10 CM  EFFECTIVE 10/08/2024

G45.3

Amaurosis fugax

 

G45.0

Vertebro-basilar artery syndrome

 

G45.1

Carotid artery syndrome (hemispheric)

 

G45.8

Other transient cerebral ischemic attacks and related syndromes

 

G45.9

Transient cerebral ischemic attack, unspecified

 

H34.01

Transient retinal artery occlusion, right eye
 
 

H34.02

Transient retinal artery occlusion, left eye
 
 

H34.03

Transient retinal artery occlusion, bilateral
 

 

H34.13

Central retinal artery occlusion, bilateral

 

H34.231

Retinal artery branch occlusion, right eye
 
 

H34.232

Retinal artery branch occlusion, left eye
 
 

H34.233

Retinal artery branch occlusion, bilateral
 

 

H34.9

Unspecified retinal vascular occlusion

 

I63.231

Cerebral infarction due to unspecified occlusion or stenosis of right carotid arteries

 

I63.232

Cerebral infarction due to unspecified occlusion or stenosis of left carotid arteries

 

I63.233

Cerebral infarction due to unspecified occlusion or stenosis of bilateral carotid arteries
 

 

I63.30

Cerebral infarction due to thrombosis of unspecified cerebral artery

 

I63.40

Cerebral infarction due to embolism of unspecified cerebral artery

 

I63.50

Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery

 

I63.59

Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery

 

I63.9

Cerebral infarction, unspecified

 

I65.21

Occlusion and stenosis of right carotid artery

 

I65.22

Occlusion and stenosis of left carotid artery

 

I65.23

Occlusion and stenosis of bilateral carotid arteries

 

I65.8

Occlusion and stenosis of other precerebral arteries

 

I66.01

Occlusion and stenosis of right middle cerebral artery
 
 

I660.2

Occlusion and stenosis of left middle cerebral artery
 
 

I66.03

Occlusion and stenosis of bilateral middle cerebral arteries
 
 

I66.11

Occlusion and stenosis of right anterior cerebral artery
 
 

I66.12

Occlusion and stenosis of left anterior cerebral artery
 
 

I66.13

Occlusion and stenosis of bilateral anterior cerebral arteries
 
 

I66.21

Occlusion and stenosis of right posterior cerebral artery
 
 

I66.22

Occlusion and stenosis of left posterior cerebral artery
 
 

I66.23

Occlusion and stenosis of bilateral posterior cerebral arteries
 

 

I67.2

Cerebral atherosclerosis

 

I67.848

Other cerebrovascular vasospasm and vasoconstriction

 

I72.0

Aneurysm of carotid artery

 

I77.71

Dissection of carotid artery

 

I77.74

Dissection of vertebral artery

 

M31.6

Other giant cell arteritis

 

R09.89

Other specified symptoms and signs involving the circulatory and respiratory systems

 

R22.1

Localized swelling, mass and lump, neck

 

R22.1

Localized swelling, mass and lump, neck

 

R55

Syncope and collapse

 

S15.002S

Unspecified injury of left carotid artery, sequela
 
 

S15.002D

Unspecified injury of left carotid artery, subsequent encounter
 
 

S15.002A

Unspecified injury of left carotid artery, initial encounter
 
 

S15.001S

Unspecified injury of right carotid artery, sequela
 
 

S15.001D

Unspecified injury of right carotid artery, subsequent encounter
 
 

S15.001A

Unspecified injury of right carotid artery, initial encounter
 

 

Z01.818

Encounter for other preprocedural examination

 

Z09

Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm

ICD 10 CM

Termination

date 10/01/2015

 

H34.00

 

Transient retinal artery occlusion, unspecified eye

 

H34.219

Partial retinal artery occlusion, unspecified eye

 

H34.239

Retinal artery branch occlusion, unspecified eye

 

H34.819

Central retinal vein occlusion, unspecified eye

 

H34.829

Venous engorgement, unspecified eye

 

H34.839

Tributary (branch) retinal vein occlusion, unspecified eye

 

H53.129

Transient visual loss, unspecified eye

 

H53.139

Sudden visual loss, unspecified eye

 

I63.139

Cerebral infarction due to embolism of unspecified carotid artery

 

I63.239

Cerebral infarction due to unspecified occlusion or stenosis of unspecified carotid

 

I65.29

Occlusion and stenosis of unspecified carotid artery

 

I66.09

Occlusion and stenosis of unspecified middle cerebral artery

 

I66.09

Occlusion and stenosis of unspecified middle cerebral artery

 

I66.19

Occlusion and stenosis of unspecified anterior cerebral artery

 

I66.29

Occlusion and stenosis of unspecified posterior cerebral artery

 

I66.9

Occlusion and stenosis of unspecified cerebral artery

 

S15.009A

Unspecified injury of unspecified carotid artery, initial encounter

ICD-10 CM

(effective date

10/01/2016)

H34.8120

Central retinal vein occlusion, left eye, with macular edema

 

H34.8121

Central retinal vein occlusion, left eye, with retinal neovascularization

 

H34.8110

Central retinal vein occlusion, right eye, with macular edema
 
 

H34.8111

Central retinal vein occlusion, right eye, with retinal neovascularization
 
 

H34.8112

Central retinal vein occlusion, right eye, stable
 
 

H34.8120

Central retinal vein occlusion, left eye, with macular edema
 
 

H34.8121

Central retinal vein occlusion, left eye, with retinal neovascularization
 

 

H34.8122

Central retinal vein occlusion, left eye, stable

 

H34.8130

Central retinal vein occlusion, bilateral, with macular edema

 

H34.8131

Central retinal vein occlusion, bilateral, with retinal neovascularization

 

H34.8132

Central retinal vein occlusion, bilateral, stable

 

H34.8310

Tributary (branch) retinal vein occlusion, right eye, with macular edema

 

H34.8311

Tributary (branch) retinal vein occlusion, right eye, with retinal neovascularization

 

H34.8312

Tributary (branch) retinal vein occlusion, right eye, stable

 

H34.8320

Tributary (branch) retinal vein occlusion, left eye, with macular edema

 

H34.8321

Tributary (branch) retinal vein occlusion, left eye, with retinal neovascularization

 

H34.8322

Tributary (branch) retinal vein occlusion, left eye, stable

 

H34.8330

Tributary (branch) retinal vein occlusion, bilateral, with macular edema

 

H34.8331

Tributary (branch) retinal vein occlusion, bilateral, with retinal neovascularization

 

H34.8332

Tributary (branch) retinal vein occlusion, bilateral, stable

ICD-10 CM

Effective Date

4/01/2020

 

I67.89

    

Other cerebrovascular disease

ICD-10 CM

(Delete date

09/30/2016)

 

H34.819

 

Central retinal vein occlusion, unspecified eye

 

H34.839

Tributary (branch) retinal vein occlusion, unspecified eye

ICD-10 CM

(Delete date

10/01/2016)

 

H34.8190

 

H34.8190 Central retinal vein occlusion, unspecified eye, with macular edema

 

H34.8191

H34.8191 Central retinal vein occlusion, unspecified eye, with retinal neovascularization

 

H34.8192

H34.8192 Central retinal vein occlusion, unspecified eye, stable

 

H34.8390

H34.8390 Tributary (branch) retinal vein occlusion, unspecified eye, with macular edema

 

H34.8391

H34.8391 Tributary (branch) retinal vein occlusion, unspecified eye, with retinal neovascularization

 

H34.8392

Tributary (branch) retinal vein occlusion, unspecified eye, stable

Applicable Modifiers

N/A

Policy History

Date

Action

Description

1/13/2025

Policy Updated

ICD-10-CM  code  G45.3 Effective 10/08/2024 

11/09/2022

`Policy Archival

Policy reviewed by the Providers Advisory Committee. No changes. Approved  policy archival.

4/05/2022

Policy updated

ICD-10 code I67.848 added ( Effective date 1/01/2022)

11/10/2021

Annual Review

Policy reviewed by the Providers Advisory Committee. No changes. 

11/11/2020

  Policy Review
  Policy reviewed by the Providers Advisory Committee. No changes. Last review ICD-10 code I67.89 Other cerebrovascular disease Added. (4/01/2020)

8/13/2020

Policy updated

ICD-10 code I67.89 Added.

11/14/2019

Policy reviewed

Policy reviewed by the Providers Advisory Committee. No changes.

11/14/2018

Policy reviewed.  New format.

 Policy reviewed by the Providers Advisory Committee.  No changes.

08/22/2017

Policy reviewed

 Unchange policy

02/17/2017

 Policy reviewed

 Unchange policy

09/20/2016

 Policy replaced

(added ICD-10)

04/11/2016

 Policy reviewed

 Unchange policy

10/22/2015

 Policy replaced

(added ICD-10)

08/06/2015

 Policy reviewed

 Unchange policy

10/14/2014

 Policy reviewed

 Unchange policy

08/08/2011

 Policy created

 New policy